Renee, AML and Breast Cancer SurvivorWith Her Daughter

An Expression Makes a World of Difference

By developing medicines to control gene expression, we aim to make a profound difference in the lives of patients and their families.

Our Message to Patients
Conley CheeChief Executive Officer

Our Message to Patients

At the heart of all our efforts at Syros is our dedication to advancing medicines that provide a profound benefit for patients with difficult-to-treat diseases.

Read Our Message

Diseases We Target

We have a singular focus on developing and delivering new standards of care for the frontline treatment of hematologic malignancies. We currently have programs in clinical development for genomically defined patients with MDS and AML. 

Read More About the Diseases We Target
Our Clinical Trials
RobertMDS Patient

Our Clinical Trials

Interested in participating in a clinical trial?

Learn More About Our Clinical Trials